# Naproxen-Powered Pain Relief Medications Kenvue Receives FDA Approval for TYLENOL with Naproxen By Kalin Ned | Published 2026-07-25 | Marketing Source: Trend Hunter, https://www.trendhunter.com/trends/tylenol-with-naproxen References: [fda.gov](https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-nonprescription-fixed-dose-combination-acetaminophen-and-naproxen-sodium-12-hour)  Kenvue Inc. has received FDA approval for TYLENOL with Naproxen — the first and only over-the-counter fixed-dose combination of 650 milligrams of acetaminophen and 220 milligrams of naproxen sodium. This product offers a non-opioid pain relief option that begins working in under 30 minutes and provides 12 hours of relief from a single dose. The TYLENOL with Naproxen formulation is backed by eight clinical studies demonstrating superior pain relief compared to either ingredient alone, and it addresses a critical gap identified in a Kenvue consumer survey where 75% of persistent pain sufferers expressed dissatisfaction with current options. The fixed-dose combination simplifies pain management by eliminating the need for patients to time or coordinate multiple over-the-counter products. The FDA has granted a three-year exclusivity period for this formulation. Image Credit: Kenvue Inc. ## Trend Insights (Trend Hunter) - Score: 8.7/10 - Popularity: 88% | Activity: 88% | Freshness: 84% - Audience gender: 50% men, 50% women - Primary generations: Millennial, Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Marketing](https://www.trendhunter.com/marketing) > [Branding](https://www.trendhunter.com/branding) ## Key Themes ### What Makes This Trend Stand Out - **Fixed-dose Analgesics:** Combined active ingredients in single OTC formats create space for differentiated pain relief products that simplify dosing and improve perceived efficacy. - **Non-opioid Pain Management:** Rising demand for safer alternatives to opioids is expanding the market for clinically validated medications that address persistent pain without prescription barriers. - **Fast-acting Long-lasting Relief:** Products that pair rapid onset with extended duration reflect consumer interest in fewer doses, greater convenience, and more predictable symptom control. ### Sectors Adopting This - **Over-the-counter Pharmaceuticals:** FDA-backed exclusivity for novel formulations can reshape competitive dynamics by rewarding brands that improve familiar medications through evidence-based combinations. - **Consumer Healthcare:** Persistent dissatisfaction with existing pain solutions highlights opportunities for trusted household brands to launch premium, research-supported wellness products. - **Pain Relief Therapeutics:** Clinical validation of dual-ingredient approaches signals a broader shift toward targeted, non-prescription therapies that bridge gaps between basic OTC remedies and prescription care. ## Related on Trend Hunter - [Chocolate-Flavored Medicines](https://www.trendhunter.com/trends/dr-cocoas.md) - [Private Label Medicine Debuts](https://www.trendhunter.com/trends/parfetts.md) - [Bio-Optimized Pain Relivers](https://www.trendhunter.com/trends/relivaid.md) - [Non-Opioid Chronic Pain Treatments](https://www.trendhunter.com/trends/nonopioid-treatment.md) - [Anti-Inflammatory Agent Studies](https://www.trendhunter.com/trends/antiinflammatory-agent.md) - [Pain Relief Campaigns](https://www.trendhunter.com/trends/paintalk.md) - [Kinesiology Pain Relief Topicals](https://www.trendhunter.com/trends/kt-pain-relief.md) - [Warming Pain Relief Solutions](https://www.trendhunter.com/trends/voltaheat.md) - [On-the-Go Pain Reliever Powders](https://www.trendhunter.com/trends/tylenol-easy-dissolve.md)